<sup>225</sup>Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic

<sup>225</sup>Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic

The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of <sup>177</sup>Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especially improved progression-f...

Full description

Bibliographic Details
Main Authors: Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
actinium-225
radionuclide production
radiolabeling
targeted radionuclide therapy
targeted alpha-therapy
radiobiology
Online Access:https://www.mdpi.com/1999-4923/15/4/1051

Similar Items

Similar Items